| Market Cap | €1.03B | |
| Enterprise Value | €882.7M | |
| Revenue | €10.33B | +27.8% |
| Gross Profit | €2.89B | +21.2% |
| EBITDA | — | — |
| Net Income | -€145.6M | −505.6% |
| Diluted EPS | -€4.81 | −529.5% |
| Free Cash Flow | — | — |
| DPS (FY2025) | €1.00 |
| Trailing yield | 2.89% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | €1.00 | — | reported |
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 8y | vs own |
|---|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | ||||||||||
| Gross Margin | — | — | — | — | 30.32% | 30.22% | 29.54% | 28.00% | 13% | |
| Operating Margin | — | 3.60% | 2.66% | 3.24% | 2.56% | — | — | — | — | |
| NOPAT Margin | — | 2.21% | 1.59% | 2.14% | 1.68% | — | — | — | — | |
| Net Margin | — | 1.43% | 0.02% | 1.99% | −0.40% | 0.63% | 0.44% | −1.41% | 7% | |
| OCF Margin | — | — | — | — | — | — | 5.92% | 6.40% | 75% | |
| Gross Profitability | — | 31.77% | 30.57% | 34.10% | 35.72% | 33.93% | 28.13% | 33.86% | 50% | |
| Capex Intensity | — | 2.00% | 1.44% | — | — | — | — | — | — | |
| ▸Returns on Capital · 4 ratios | ||||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||||||||
| ▸Earnings quality · 4 ratios | ||||||||||
| ▸Liquidity & coverage · 1 ratios | ||||||||||
| ▸Leverage · 5 ratios | ||||||||||
| ▸Working capital · 7 ratios | ||||||||||
| ▸Capital allocation · 2 ratios | ||||||||||
| ▸Per share · 3 ratios | ||||||||||
The five drivers multiply to -2.1% vs reported ROE -2.1%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | €7.35B | €7.49B | €8.04B | €7.95B | €7.87B | €8.08B | €10.33B |
| YoY % | +1.9% | +7.4% | -1.2% | -0.9% | +2.6% | +27.8% | |
| Cost of Revenue | — | — | — | €5.54B | €5.49B | €5.69B | €7.44B |
| YoY % | -0.8% | +3.6% | +30.6% | ||||
| Gross Profit | €2.24B | €2.19B | €2.37B | €2.41B | — | — | — |
| YoY % | -2.2% | +8.6% | +1.5% | ||||
| Operating Income | €264.7M | €199.4M | €260.4M | €203.6M | — | — | — |
| YoY % | -24.7% | +30.6% | -21.8% | ||||
| Equity Method Income | — | — | -€200,000 | €200,000 | €100,000 | €1.3M | €3.7M |
| YoY % | -50.0% | +1200.0% | +184.6% | ||||
| Pretax Income | €185.6M | €148.0M | €218.6M | €158.3M | -€38.5M | €94.7M | -€37.5M |
| YoY % | -20.3% | +47.7% | -27.6% | ||||
| Income Tax | €71.5M | €59.6M | €74.1M | €54.4M | €30.6M | €31.7M | €24.5M |
| YoY % | -16.6% | +24.3% | -26.6% | -43.8% | +3.6% | -22.7% | |
| Income from Continuing Operations | €114.1M | €88.4M | €144.5M | €103.9M | -€69.1M | €63.0M | -€62.0M |
| YoY % | -22.5% | +63.5% | -28.1% | ||||
| Income from Discontinued Operations | -€10.2M | -€94.4M | €15.3M | -€132.0M | €124.7M | -€19.5M | -€78.4M |
| Net Income (incl. NCI) | €103.9M | -€6.0M | €159.8M | -€28.1M | €55.6M | €43.5M | -€140.4M |
| YoY % | -21.8% | ||||||
| Minority Interest (P&L) | -€1.0M | -€7.2M | -€500,000 | €3.9M | €5.9M | €7.6M | €5.2M |
| YoY % | +51.3% | +28.8% | -31.6% | ||||
| Net Income | €104.9M | €1.2M | €160.3M | -€32.0M | €49.7M | €35.9M | -€145.6M |
| YoY % | -98.9% | +13258.3% | -27.8% | ||||
| EPS (Basic) | €3.96 | €0.05 | €6.02 | -€1.19 | €1.80 | €1.25 | -€4.81 |
| YoY % | -98.7% | +11940.0% | -30.6% | ||||
| EPS (Diluted) | €3.92 | €0.04 | €5.38 | -€1.19 | €1.61 | €1.12 | -€4.81 |
| YoY % | -99.0% | +13350.0% | -30.4% | ||||
| Dividends Declared per Share | — | — | — | €2 | €1 | €0 | €1 |
| YoY % | -30.0% | -67.9% | +122.2% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
